These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 34107584
1. [Liraglutide alleviates lipotoxic liver cell damage and promotes autophagy to improve non-alcoholic fatty liver]. Zhang Q, Liu Q, Niu CY. Zhonghua Gan Zang Bing Za Zhi; 2021 May 20; 29(5):456-461. PubMed ID: 34107584 [Abstract] [Full Text] [Related]
2. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway. He Q, Sha S, Sun L, Zhang J, Dong M. Biochem Biophys Res Commun; 2016 Aug 05; 476(4):196-203. PubMed ID: 27208776 [Abstract] [Full Text] [Related]
4. Liraglutide protects pancreatic β-cells against free fatty acids in vitro and affects glucolipid metabolism in apolipoprotein E-/- mice by activating autophagy. Wang J, Wu J, Wu H, Liu X, Chen Y, Wu J, Hu C, Zou D. Mol Med Rep; 2015 Sep 05; 12(3):4210-4218. PubMed ID: 26080706 [Abstract] [Full Text] [Related]
5. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway. Fang Y, Ji L, Zhu C, Xiao Y, Zhang J, Lu J, Yin J, Wei L. Front Cell Dev Biol; 2020 Sep 05; 8():602574. PubMed ID: 33330497 [Abstract] [Full Text] [Related]
6. The preventive effect of liraglutide on the lipotoxic liver injury via increasing autophagy. He Y, Ao N, Yang J, Wang X, Jin S, Du J. Ann Hepatol; 2020 Sep 05; 19(1):44-52. PubMed ID: 31787541 [Abstract] [Full Text] [Related]
7. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy. Zhou SW, Zhang M, Zhu M. Mol Med Rep; 2014 Nov 05; 10(5):2351-7. PubMed ID: 25230688 [Abstract] [Full Text] [Related]
8. Liraglutide ameliorates hepatic steatosis via retinoic acid receptor-related orphan receptor α-mediated autophagy pathway. Yu X, Bian X, Zhang H, Yang S, Cui D, Su Z. IUBMB Life; 2023 Oct 05; 75(10):856-867. PubMed ID: 37310057 [Abstract] [Full Text] [Related]
9. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. Sharma S, Mells JE, Fu PP, Saxena NK, Anania FA. PLoS One; 2011 Oct 05; 6(9):e25269. PubMed ID: 21957486 [Abstract] [Full Text] [Related]
10. [Study on anti- fibrotic mechanism of Fuzheng -Huayu formula to suppress autophagy in mice]. Huang LW, Jiang N, Ping J, Zhang J, Xu LM. Zhonghua Gan Zang Bing Za Zhi; 2019 Aug 20; 27(8):621-627. PubMed ID: 31594080 [Abstract] [Full Text] [Related]
11. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line. Zhou D, Li BH, Wang J, Ding YN, Dong Y, Chen YW, Fan JG. PLoS One; 2016 Aug 20; 11(10):e0165224. PubMed ID: 27760195 [Abstract] [Full Text] [Related]
12. Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway. Wang YG, Yang TL. Exp Ther Med; 2015 Nov 20; 10(5):1777-1783. PubMed ID: 26640549 [Abstract] [Full Text] [Related]
13. Liraglutide promotes autophagy by regulating the AMPK/mTOR pathway in a rat remnant kidney model of chronic renal failure. Xue L, Pan Z, Yin Q, Zhang P, Zhang J, Qi W. Int Urol Nephrol; 2019 Dec 20; 51(12):2305-2313. PubMed ID: 31531806 [Abstract] [Full Text] [Related]
14. Oridonin interferes with simple steatosis of liver cells by regulating autophagy. Cheng B, Jin J, Liu D, Shi T, Fu X, Liu C, Liu S, Wu R. Tissue Cell; 2021 Oct 20; 72():101532. PubMed ID: 33823340 [Abstract] [Full Text] [Related]
15. [Exendin-4 promotes autophagy to relieve lipid deposition in a NAFLD cell model by activating AKT/mTOR signaling pathway]. Lin C, Fang J, Xiang Q, Zhou R, Yang L. Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul 20; 41(7):1073-1078. PubMed ID: 34308859 [Abstract] [Full Text] [Related]
16. [Urolithin A inhibits inflammation and oxidative stress induced by high lipid in hepatocytes via activating Nrf2 pathway and autophagy]. Yin C, Wang Y, Peng Y, Zhang R, Sun N, Shi C, Liu Q. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Nov 20; 37(11):973-980. PubMed ID: 34809736 [Abstract] [Full Text] [Related]
18. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet. Hao T, Chen H, Wu S, Tian H. Mol Med Rep; 2019 Jul 20; 20(1):701-708. PubMed ID: 31180545 [Abstract] [Full Text] [Related]
19. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK]. Zhao XY, Zhang LL, Suolang QZ, Yang GY, Li L, Li SB, Chen WW. Zhonghua Gan Zang Bing Za Zhi; 2014 Nov 20; 22(11):849-53. PubMed ID: 25531383 [Abstract] [Full Text] [Related]
20. Upregulated SOCC and IP3R calcium channels and subsequent elevated cytoplasmic calcium signaling promote nonalcoholic fatty liver disease by inhibiting autophagy. Zhang L, Zhang Y, Jiang Y, Dou X, Li S, Chai H, Qian Q, Wang M. Mol Cell Biochem; 2021 Aug 20; 476(8):3163-3175. PubMed ID: 33864571 [Abstract] [Full Text] [Related] Page: [Next] [New Search]